Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer

Molecular Endocrinology

Volumn 23, Issue 9, 2009, Pages 1397-1405

  Zhu, Xuegong ^a   Asa, Sylvia L ^a   Ezzat, Shereen ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; ESTROGEN RECEPTOR; FAS ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; HISTONE; ISOPROTEIN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; RNA; TRANSCRIPTION FACTOR RUNX2; TRICHOSTATIN A;

ACETYLATION; ALLELE; ARTICLE; BINDING SITE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DEACETYLATION; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTRON; KNOCKOUT GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ACETYLATION; ALTERNATIVE SPLICING; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HISTONES; HUMANS; INTRONS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2;

EID: 69449083319     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0071     Document Type: Article

References (31)

1. Givol D, Yayon A 1992 Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6:3362-3369 (Pubitemid 23007101)
2. Yan G, Wang F, Fukabori Y, Sussman D, Hou J, McKeehan WL 1992 Expression and transformation of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the exon at alternate 3′-acceptor site. Biochem Biophys Res Commun 183:423-430
3. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093 (Pubitemid 47014426)
4. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, et al. 2007 A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870-874 (Pubitemid 47014500)
5. Luqmani YA, Graham M, Coombes RC 1992 Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 66:273-280
6. Tannheimer SL, Rehemtulla A, Ethier SP 2000 Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res 2:311-320 (Pubitemid 32223612)
7. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M 1996 Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297 (Pubitemid 26195013)
8. Luo Y, Ye S, Kan M, McKeehan WL 2006 Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb. J Cell Biochem 97:1241-1258
9. Thisse B, Thisse C, Weston JA 1995 Novel FGF receptor (ZFGFR4) is dynamically expressed in mesoderm and neurectoderm during early zebrafish embryogenesis. Dev Dyn 203:377-391
10. Thisse B, Thisse C 2005 Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol 287:390-402 (Pubitemid 41636772)
11. Baraniak AP, Lasda EL, Wagner EJ, Garcia-Blanco MA 2003 A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements. Mol Cell Biol 23:9327-9337
12. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL 1993 Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13:4513-4522 (Pubitemid 23220358)
13. Luqmani YA, Bansal GS, Mortimer C, Buluwela L, Coombes RC 1996 Expression of FGFR2 BEK and K-SAM mRNA variants in normal and malignant human breast. Eur J Cancer 32A:518-524 (Pubitemid 26103311)
14. Moffa AB, Tannheimer SL, Ethier SP 2004 Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Mol Cancer Res 2:643-652 (Pubitemid 39557667)
15. Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BA 2008 Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6:e108 (Pubitemid 351824744)
16. Simarro M, Mauger D, Rhee K, Pujana MA, Kedersha NL, Yamasaki S, Cusick ME, Vidal M, Garcia-Blanco MA, Anderson P 2007 Fas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicing. Proc Natl Acad Sci USA 104:11370-11375 (Pubitemid 47175147)
17. Revest JM, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I, Dickson C 2001 Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol 231:47-62 (Pubitemid 32198386)
18. St Bernard R, Zheng L, Liu W, Winer D, Asa SL, Ezzat S 2005 Fibroblast growth factor receptors as molecular targets in thyroid carcinoma. Endocrinology 146:1145-1153 (Pubitemid 40289303)
19. Grose R, Dickson C 2005 Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev 16:179-186 (Pubitemid 40616115)
20. Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, Yoshida T, Ferry G, Tucker G, Poupon MF, Chopin D, Thiery JP, Radvanyi F 1999 Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb inhumanbladder cancer. Oncogene 18:7234-7243 (Pubitemid 30032102)
21. Feng S, Wang F, Matsubara A, Kan M, McKeehan WL 1997 Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 57:5369-5378 (Pubitemid 27516376)
22. Zhang Y, Wang H, Toratani S, Sato JD, Kan M, McKeehan WL, Okamoto T 2001 Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc Natl Acad Sci USA 98:11336-11340 (Pubitemid 32928729)
23. Kondo T, Zheng L, Liu W, Kurebayashi J, Asa SL, Ezzat S 2007 Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression. Cancer Res 67:5461-5470 (Pubitemid 46997287)
24. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, Robertson JF, Aparicio S, Ellis IO, Brenton JD, Caldas C 2007 A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 26:1507-1516 (Pubitemid 46340809)
25. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavaré S, Caldas C, Miska EA 2007 MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8:R214 (Pubitemid 351917462)
26. Zhu X, Lee K, Asa SL, Ezzat S 2007 Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells. Am J Pathol 170:1618-1628 (Pubitemid 47339306)
27. Naimi B, Latil A, Fournier G, Mangin P, Cussenot O, Berthon P 2002 Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate. Prostate 52:245-252 (Pubitemid 34791225)
28. Bernard-Pierrot I, Ricol D, Cassidy A, Graham A, Elvin P, Caillault A, Lair S, Broët P, Thiery JP, Radvanyi F 2004 Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor. Oncogene 23:9201-9211
29. Mendoza S, David H, Gaylord GM, Miller CW 2005 Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes. Cancer Genet Cytogenet 158:142-147 (Pubitemid 40417696)
30. Simpson DJ, Bicknell EJ, Buch HN, Cutty SJ, Clayton RN, Farrell WE 2003 Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss. Genes Chromosomes Cancer 37:225-236
31. Ezzat S, Yu S, Asa SL 2003 Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5′ fibroblast growth factor receptor-4 promoter. Am J Pathol 163:1177-1184 (Pubitemid 37040153)